MultiCell Technologies, Inc. Share Price
Equities
MCET
US62544S2005
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -90.00% | 0.00% | 0.00% |
2015 | MultiCell Technologies, Inc. Auditor Raises 'Going Concern' Doubt | CI |
2014 | MultiCell Technologies Files Novel Antibody-Drug Conjugate Patent Application | CI |
Sales 2013 | 49.32K 4.12M | Sales 2014 | 49.32K 4.12M | Capitalization | 2.16M 181M |
---|---|---|---|---|---|
Net income 2013 | -1M -83.49M | Net income 2014 | - 0 | EV / Sales 2013 | 34.9 x |
Net cash position 2013 | 39.11K 3.27M | Net Debt 2014 | 90.04K 7.52M | EV / Sales 2014 | 45.7 x |
P/E ratio 2013 |
-1.09
x | P/E ratio 2014 |
-4.9
x | Employees | - |
Yield 2013 * |
-
| Yield 2014 |
-
| Free-Float | 90.01% |
1 day | -90.00% |
Date | Price | Change | Volume |
---|---|---|---|
09/24/09 | 0.000001 | -90.00% | 450,000 |
08/24/08 | 0.00001 | +900.00% | 200,000 |
06/24/06 | 0.000001 | 0.00% | 1,581,688 |
02/24/02 | 0.000001 | 0.00% | 3,000 |
Delayed Quote OTC Markets, May 09, 2024 at 10:32 pm IST
More quotes1st Jan change | Capi. | |
---|---|---|
0.00% | 5K | |
+17.96% | 44.96B | |
+48.77% | 41.85B | |
+1.17% | 42.65B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- MCET Stock